Table 1 Cox regression analyses of factors associated with OS and TTR of HCC patients (n = 96).

From: H2A.Z acetylation by lincZNF337-AS1 via KAT5 implicated in the transcriptional misregulation in cancer signaling pathway in hepatocellular carcinoma

Variables

Overall survival

Time to recurrence

Hazard ratio (95%CI)

P-value

Hazard ratio (95%CI)

P-value

Sex (female vs. male)

1.011 (0.987–1.034)

0.371

1.014 (0.991–1.038)

0.226

Age, Y (≤51 vs. >51)

1.671 (0.571–1.504)

0.759

0.797 (0.492–1.294)

0.359

Tumor differentiation (III–IV vs. I–II)

2.625 (0.629–4.440)

0.303

1.626 (0.683–3.870)

0.272

AFP (ng/mL; >20 vs. ≤20)

1.518 (0.762–3.023)

0.235

1.019 (0.529–1.965)

0.955

HbsAg (negative vs. positive)

1.055 (0.443–2.513)

0.904

1.099 (0.438–2.757)

0.841

Liver cirrhosis (no vs. yes)

0.990 (0.463–2.114)

0.978

1.002 (0.439–2.288)

0.996

Tumor number (multiple vs. single)

1.056 (0.405–2.775)

0.911

0.817 (0.323–2.064)

0.669

Tumor encapsulation (yes vs.no)

1.131 (0.478–2.667)

0.779

1.491 (0.646–3.474)

0.353

Vascular invasion (yes vs.no)

2.625 (1.483–2.625)

0.001**

2.027 (1.152–3.570)

0.014*

TNM stage (III–IV vs. I–II)

1.958 (1.079–3.553)

0.027*

1.815 (1.024–3.217)

0.041*

H2A.Z (high vs. low)

2.917 (1.456–5.845)

0.003**

2.377 (1.250–4.522)

0.008**

  1. H2A.Z H2A histone family member Z, TNM tumor, node, and metastasis, AFP alpha-fetoprotein.
  2. *p < 0.05, **p < 0.01.